Re­port — Sanofi close to bag­ging Flex­ion in a loom­ing $1B-plus buy­out, shares rock­et up

Sanofi has struck a deal to buy Flex­ion $FLXN and the pain drug it now has un­der re­view at the FDA, ac­cord­ing to a scoop …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.